Courage Over Cancer

A collection of resources dedicated to empowering our community.

Mesa, Mays Cancer Center play role in getting new medications for blood cancers approved

Ruben A. Mesa, MD, FACP, executive director of the Mays Cancer Center, home to UT Health San Antonio MD Anderson Cancer Center, has played a key role as both an investigator and aiding the drug development for the past eight years to get RoPEG INFa2b (besremi) approved in PV.

Mays Cancer Center researchers to present findings, discuss disparities during San Antonio Breast Cancer Symposium

Researchers from the Mays Cancer Center, home to UT Health San Antonio MD Anderson Cancer Center, will present results of multiple lines of study Dec. 7-10 during the 2021 San Antonio Breast Cancer Symposium.

Yoga improves quality of life in men with new diagnosis of prostate cancer

Yoga improved physical and mental well-being and promoted a robust immune response in a randomized clinical trial of men with prostate cancer.

Robotic surgical approach provides faster recovery for testicular cancer patients

The newer procedure is called robotic retroperitoneal lymph node dissection, or robotic RPLND. Although the procedure has been previously reported, Mays Cancer Center developed technical improvements to make it safer, more effective and applicable in new indications.

Photo of doctors looking at tumor images

Glioblastoma recurrence and clues to blunt it

It’s a medical conundrum. Ionizing radiation, which at first extends the survival of glioblastoma patients after surgery, may later, ironically, help drive the brain cancer’s aggressive, untreatable recurrence. Dr. Sandeep Burma and a team of investigators at the Mays Cancer Center, home to UT Health San Antonio MD Anderson Cancer Center, are studying companion treatments to see if any can eliminate this Jekyll and Hyde property of ionizing radiation.

Amelie G. Ramirez to lead Women in Cancer Research Council

Amelie G. Ramirez, DrPH, MPH, director of Salud America! at UT Health San Antonio and a leading health disparities researcher, has been selected to serve as the 2021-2022 chair of the Women in Cancer Research Council of the American Association for Cancer Research (AACR).

Breast cancer survivor clinical trial offers recovery and hope

Lindsay Fry is a breast cancer survivor who was first diagnosed in 2019. Her treatment regimen of surgery, radiation and chemotherapy began in fall 2019. Shortly after completing her treatment, Fry became the first participant in a new clinical trial at The University of Texas Health Science Center at San Antonio (UT Health San Antonio) that aims to help breast cancer survivors regain their energy and remain cancer free.